The direct trial (daily-dose consensus interferon and ribavirin: efficacy of combined therapy): Treatment of non-responders to previous pegylated interferon plus ribavirin: Sustained virologic response data

被引：0
|
作者：
Bacon, Bruce
Regev, Arie
Ghalib, Reem H.
Morelli, Giuseppe
Rothstein, Kenneth D.
Shiffman, Mitchell L.
Hossanein, Tarek
Hammond, Janet
机构：
[1] St Louis Univ, Sch Med, Liver Ctr, St Louis, MO 63103 USA
[2] Univ Miami, Coral Gables, FL 33124 USA
[3] Methodist Hosp, Liver Inst, Dallas, TX USA
[4] Univ Florida, Gainesville, FL 32611 USA
[5] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[6] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
[8] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
168
引用
收藏
页码：311A / 312A
页数：2
相关论文
共 50 条
  • [1] Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin
    Hassanein, Tarek
    Ghalib, Reem H.
    Zein, Nizar N.
    Rothstein, Kenneth D.
    Joshi, Shobha N.
    Kwo, Paul Yien
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 824A - 824A
  • [2] Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
    Stauber, R
    Munda-Steindl, P
    Hackl, F
    Schüutze, K
    Datz, C
    Hofer, H
    Hegenbarth, K
    Jessner, W
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 135
  • [3] Sustained virologic response with albinterferon alfa-2b/ribavirin treatment in prior interferon therapy non-responders
    Nelson, David R.
    Rustgi, Vinod K.
    Balan, Vijayan
    Sulkowski, Mark
    Davis, Gary L.
    Muir, Andrew
    Lambiase, Louis
    Dickson, Rolland C.
    Wiesner, Russell H.
    McHutchison, John G.
    Pulkstenis, Erik
    Cronin, Patrick
    Subramanian, G. M.
    HEPATOLOGY, 2007, 46 (04) : 256A - 256A
  • [4] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [5] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [6] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [7] EFFICACY OF DAILY DOSE CONSENSUS INTERFERON ALFACON-1 (CIFN) AND RIBAVIRIN IN PREVIOUS NON RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH ADVANCED FIBROSIS FROM CHRONIC HEPATITIS C
    Mantry, Parvez S.
    Barnes, Maisha
    HEPATOLOGY, 2008, 48 (04) : 893A - 894A
  • [8] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [9] Efficacy of daily consensus interferon and ribavirin compared to PEG-interferon α-2b and ribavirin in non-responders with chronic Hepatitis C
    Dollinger, MM
    Dridi, Y
    Lesske, J
    Behl, S
    Fleig, WE
    HEPATOLOGY, 2005, 42 (04) : 691A - 692A
  • [10] High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 582A - 582A
12345